Clinical Trial Update: The Objective of This Study is to Evaluate the Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD) Who Have Had an Inadequate Response to Antidepressants Alone [Phase 3]

View source ↗

Summary

Phase 3 trial assessing cariprazine as an adjunctive treatment to antidepressants in adults with major depressive disorder who had an inadequate response to ant…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• cariprazine (cariprazine)

Snippet

Sponsor: AbbVie | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED | Results posted: 2022-09-21